Mankind Pharma on Monday said it will acquire Panacea Biotec Pharma's formulations brands, for India and Nepal markets, for Rs 1,872 crore
The Covid-19 pandemic has not led a huge demand for innovations in the pharma sector, but has also given a fillip to research and development (R&D), which have become the most important segment needed to meet the rising demand of more vaccines, along
Biocon Biologics Ltd (BBL) the subsidiary of Biocon on Monday said it has entered into a definitive agreement to acquire Viatris’ biosimilars assets for $3.34 billion. Biocon Biologics Ltd (BBL) the subsidiary of Biocon on Monday said it has entered.
With the increasing geo-political tensions between Russia and Ukraine, the Indian pharmaceutical segment is expected to witness a tremor in its operations.
The Russia-Ukraine crisis and sanctions against Russia by many western countries including the US may cause some damage to Indian pharmaceutical exports, executives of pharma industry told.
A delegation of government officials and pharma industry reps set to visit Australia next week to strengthen ties and discuss ways of speeding up approvals for Indian pharmaceuticals
Precision medicine is one of the ways through which health care providers can render and plan specific care for their patients. This can be done based on an individual’s genes or the genes in their cancer cells.
West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration today announced the appointment of Ravikrishna Chebolu as General Manager of its India operations.West Pharmaceutical Services, Inc.
The Drug Controller General of India (DCGI) recommended emergency use of Biological E's Covid-19 vaccine Corbevax in the 12 to 18 years age-group. The Drug Controller General of India (DCGI) recommended emergency use of Biological E's Covid-19 vaccin
In a $17.5 million agreement, Bahrain fund manager investcorp acquires a stake in India's specialist formulations maker V-Ensure Pharma Technologies.